NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD)

Clinical trials for NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD) explained in plain language.

Never miss a new study

Get alerted when new NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD) trials appear

Sign up with your email to follow new studies for NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New eye injection schedules tested to fight blinding disease

Disease control Not yet recruiting

This study is testing two different treatment schedules for aflibercept 8mg injections in the eye to control Polypoidal Choroidal Vasculopathy (PCV), a condition that can cause vision loss. It aims to see which schedule is better at improving and maintaining vision over one year …

Matched conditions: NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD)

Phase: PHASE4 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD)

Get alerted when new NEOVASCULAR AGE RELATED MACULAR DEGENERATION (AMD) trials appear

New eye injection schedules tested to fight blinding disease